COMP <GO>
RXO vs AMZN // FORWARD P/E MULTIPLE
RXO Inc. (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: RXO 5
— AMZN 4
▲ FORWARD P/E MULTIPLE LEADER: RXO
LAST: $27.49 (-0.58%) • MKT CAP: $4.56B
forward-pe
22.0x
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
forward-pe
22.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RXO VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RXO | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.90% | 17.61% | -20.51 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.18% | -1.81% | +1.63 | RXO | /fcf-yield <GO> |
| Operating Margin | -1.40% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -1.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.35 | 3.32 | +0.03 | RXO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | RXO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.73% | +0.47 | AMZN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 38.3 | +18.38 | RXO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 1.46 | -0.37 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 22.0x | 22.8x | -0.75 | RXO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.56B | $2.59T | -$2.59T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RXO REV | AMZN REV | RXO GROSS % | AMZN GROSS % | RXO FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $5.74B | $0 | 44.0% | — | -$8.0M | $10.56B |
| FY 2024 | $4.55B | $0 | 44.0% | — | -$57.0M | $42.95B |
| FY 2023 | $3.93B | $0 | 44.0% | — | -$87.7M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RXO // BETA 1.09
AMZN // BETA 1.46